Mitochondrial Porin in Bioenergetic Defects in Huntingtons Disease

亨廷顿病生物能缺陷中的线粒体孔蛋白

• 批准号: 8271933
• 负责人: Nickolay Brustovetsky
• 金额: $ 33.79万
• 依托单位: INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS
• 依托单位国家: 美国
• 财政年份: 2012
• 资助国家: 美国
• 起止时间: 2012-02-15 至 2016-01-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/8271933
• 关键词: Address; Affect; American; Applications Grants; Binding; Biochemical; Bioenergetics; Biological Assay; Brain; Brain Injuries; Cells; Chimeric Proteins; Co-Immunoprecipitations; Confocal Microscopy; Corpus striatum structure; Cytosol; Data; Defect; Development; Emotional; Face; Family; Foundations; Future; Gene Mutation; Genetic Risk; Glutathione S-Transferase; Goals; Huntington Disease; Individual; Inherited; Injury; Inner mitochondrial membrane; Knock-in Mouse; Knowledge; Laboratories; Lasers; Lead; Life; Link; Literature; Membrane Potentials; Methodology; Mitochondria; Molecular; Mus; Mutation; Nerve Degeneration; Neurodegenerative Disorders; Neurologic; Neurons; Outer Mitochondrial Membrane; Oxidative Stress; Patch-Clamp Techniques; Pathogenesis; Pathway interactions; Patients; Play; Predisposition; Proteins; Research; Respiration; Role; Scheme; Societies; Solid; Superoxides; Surface Plasmon Resonance; Synapses; Testing; Therapeutic; Three-Dimensional Image; Tissues; Transgenic Organisms; Triplet Multiple Birth; United States; Voltage-Dependent Anion Channel; Wild Type Mouse; base; design; fighting; human Huntingtin protein; image processing; improved; mitochondrial dysfunction; mitochondrial membrane; mouse model; mutant; neuron loss; neuronal survival; neurotoxicity; novel; novel therapeutics; patch clamp; polyglutamine; porin; programs; proteoliposomes; reconstitution; respiratory; therapeutic target; uptake

DESCRIPTION (provided by applicant): Huntington's Disease (HD) is an inherited, neurodegenerative disorder associated with the abnormal expansion of CAG triplet that encodes a polyglutamine domain in huntingtin, a 350 kDa protein expressed in various tissues. A mechanistic link between Htt gene mutation and neuronal loss leading to neurological abnormalities in HD has not yet been determined, but mitochondrial dysfunction has emerged as a causal factor involved in HD pathogenesis. Despite extensive studies, the mechanisms of mitochondrial dysfunction in HD remain unclear. The overall objectives of the proposed study are to clarify the role of mitochondrial porin, also known as voltage-dependent anion channel (VDAC), in mutant huntingtin (mHtt)-induced mitochondrial dysfunction and abnormal mitochondrial fragmentation in mHtt-expressing neurons. In the proposed study, we will test a novel hypothesis that mHtt binds to VDAC and inhibits metabolite transport across the OMM, leading to mitochondrial dysfunction, Ca2+ handling defects, mitochondrial oxidative stress, and augmented mitochondrial fission. We will address the following questions: (1) Does mHtt diminish VDAC transport activity by binding to the channel? (2) Is VDAC inhibition accountable for respiratory suppression, depolarization, and accumulation of superoxide anion O2¿ - in mitochondria exposed to mHtt? (3) Does mHtt result in increased susceptibility to mitochondrial Ca2+-induced injury and decreased Ca2+ uptake capacity by inhibiting VDAC? (4) Does VDAC inhibition lead to mitochondrial oxidative stress and augmented mitochondrial fission in cultured neurons expressing mHtt? To answer these questions we will use VDAC-reconstituted giant proteoliposomes in conjunction with electrophysiological patch-clamp technique and glutathione-S-transferase (GST)-polyQ fusion proteins. We will use synaptic and non-synaptic purified brain mitochondria isolated from wild-type mice and transgenic and knock-in HD mouse models in combination with modern pharmacological, biochemical, and bioenergetic methodologies. To analyze mitochondrial dynamics, we will use live-cell, laser spinning-disk confocal microscopy followed by sophisticated image processing and quantitative 3D image rendering applied to cultured striatal and cortical neurons derived from wild-type and HD mice with mitochondria visualized by mitochondrially targeted fluorescent proteins. At the conclusion of this research program, we will establish the role of VDAC inhibition in mitochondrial dysfunction, Ca2+ handling defects, mitochondrial oxidative stress, and augmented fission in mitochondria exposed to mHtt. Thus, our study will provide novel, vital knowledge about molecular mechanisms of mitochondrial dysfunction in HD and build a platform for future HD research. This will lay a solid foundation for creating treatments aimed at improving mitochondrial functioning and neuronal survival in HD. Most importantly, this will immensely help in the development of new therapeutic strategies to alleviate neurological deficits in HD and significantly diminish suffering of HD patients, improve quality of their life, and lessen the emotional and financial burden on the family and the whole society. PUBLIC HEALTH RELEVANCE: The proposed research is aimed at elucidating the molecular mechanisms of mitochondrial dysfunction that might contribute to development of Huntington Disease (HD), one of the most devastating neurodegenerations. The proposed research will significantly advance our knowledge about molecular mechanisms involved in mitochondrial injury and brain damage in HD and will lead to the design of more effective therapeutic strategies directed at protecting mitochondria and neurons thus diminishing neurological abnormalities in HD.

描述（由申请人提供）：亨廷顿病（HD）是一种遗传性神经退行性疾病，与CAG三联体异常扩增有关，CAG三联体编码亨廷顿蛋白中的聚谷氨酰胺结构域，在各种组织中表达350 kDa蛋白。Htt基因突变与神经元丢失导致HD神经异常之间的机制联系尚未确定，但线粒体功能障碍已成为HD发病的一个因果因素。尽管进行了大量的研究，但HD患者线粒体功能障碍的机制仍不清楚。该研究的总体目标是阐明线粒体孔蛋白（也称为电压依赖性阴离子通道（VDAC））在突变型亨廷顿蛋白（mHtt）诱导的线粒体功能障碍和表达mHtt的神经元线粒体异常断裂中的作用。在拟议的研究中，我们将验证一个新的假设，即mHtt与VDAC结合并抑制代谢物在OMM的运输，导致线粒体功能障碍，Ca2+处理缺陷，线粒体氧化应激和线粒体裂变增强。我们将解决以下问题：(1)mHtt是否通过与通道结合而降低VDAC的运输活性？(2)暴露于mHtt的线粒体中，VDAC抑制是否与呼吸抑制、去极化和超氧阴离子O2¿-积累有关？(3) mHtt是否通过抑制VDAC导致对线粒体Ca2+诱导损伤的易感性增加和Ca2+摄取能力降低？(4) VDAC抑制是否导致表达mHtt的培养神经元线粒体氧化应激和线粒体裂变增强？为了回答这些问题，我们将使用vdac重组的巨型蛋白脂质体，结合电生理膜片钳技术和谷胱甘肽- s -转移酶(GST)-polyQ融合蛋白。我们将使用从野生型小鼠、转基因和敲入型HD小鼠模型中分离的突触和非突触纯化脑线粒体，并结合现代药理学、生化和生物能量方法。为了分析线粒体动力学，我们将使用活细胞激光共聚焦显微镜，然后进行复杂的图像处理和定量3D图像渲染，应用于野生型和HD小鼠培养的纹状体和皮质神经元，线粒体靶向荧光蛋白显示线粒体。在本研究计划的结论中，我们将确定VDAC抑制在线粒体功能障碍、Ca2+处理缺陷、线粒体氧化应激和线粒体暴露于mHtt中的增强裂变中的作用。因此，我们的研究将为HD线粒体功能障碍的分子机制提供新的、重要的知识，并为未来HD的研究搭建平台。这将为创造旨在改善HD患者线粒体功能和神经元存活的治疗方法奠定坚实的基础。最重要的是，这将极大地帮助开发新的治疗策略，以减轻HD患者的神经功能缺陷，显著减少HD患者的痛苦，提高他们的生活质量，减轻家庭和整个社会的情感和经济负担。